AIIMS to Begin Booster Trial of Bharat Biotech’s Intranasal Vaccine Today on Those Jabbed With Covaxin, Covishield
The All India Institute of Medical Sciences, Delhi (AIIMS) will start a booster dose trial of Indian firm Bharat Biotech’s […]
The All India Institute of Medical Sciences, Delhi (AIIMS) will start a booster dose trial of Indian firm Bharat Biotech’s […]
New Delhi: The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on
The Subject Expert Committee (SEC) of India’s drug authority is set to meet to examine Bharat Biotech’s application for its
Bharat Biotech  New Delhi: The Drug Controller General of India (DCGI) gave Bharat Biotech approval for emergency use authorisation